2016 Report details for project: PHE Science Hub

Project name: PHE Science Hub - there are 7 reports for this project: 2013, 2014, 2015, 2016, 2017, 2018, 2019
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2016 (data is from Sept 2015)
Category: Infrastructure - see all reports for this category
Description: The programme, previously called Chrysalis, transferred to Public Health England on 31st March 2013. The vision under PHE has continued to develop and builds upon and strengthens the strategic case for an integrated public health service, as well as address the urgent re-provision of facilities currently at Porton. The business case is based on the delivery of a “hub and spoke” model for public health science in PHE, with a preferred option to co-locate Porton research, Colindale and London HQ functions onto a site in Harlow Essex.
DCA (RAG): Amber
DCA text: The Chancellor announced in September 2015 an investment of £350 million for the development of the Porton only "in scope" elements to the GSK site at Harlow. The Outline Business Case is based on the co-location of the other elements from Colindale and London based National functions and PHE headquarters. At the time of writing, these elements were being considered as part of the Spending Review in November 2015. Non-approval of the other elements would cause a significant delay due to re-design etc., hence the Amber delivery confidence. As at Q2 2015/16, any delay in an overall OBC decision also raises risks around potential loss of the GSK site and supply chain interest. These have been actively managed and the Chancellor's September announcement provided significant mitigation but the risks at the time also supported an Amber assessment.
Start date: 2013-06-28
End date: 2023-03-31
Schedule text: The OBC was submitted on time at the end of July 2014. A final decision by HMT/DH was delayed from September 2014 until after the General Election. The programme was working on the assumption of a decision by the end of July 2015 and the key risks were based on this forward plan. Based on this assumption, the subsequent objective is to ramp up and commence the next stage of design at the beginning of January 2016. As at Q2 2015/16 , DH Ministers had approved the OBC but HMT had yet to make a final decision. In the event, on 17 September 2015, an interim decision was announced by the Chancellor for the “Porton only” element to go ahead at Harlow, with the remaining scope of Colindale, Whitechapel and London HQ functions to be considered as part of the Spending review (SR) in November 2015. The Programme Board subsequently agreed that the readiness activities should continue on the assumption of a positive outcome from the SR for the full scope. As of Q2 '15/16, the delays had led to an 15 month delay in the programme.
Baseline: £197.25m
Forecast: £135.56m
Variance: -31.28%
Variance text: The positive variance is driven by the slippage in the assumed Outline Business Case decision date.
Whole Life Cost: £10,447.57m
WLCost text: Whole life costs reflect the operating costs of the in scope activities covering the period of the programme plus a further 60 years. Costs for the 60 years are at 2023/24 prices.
Notes1:
Notes2:
Sourcefile: IPA_2016.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.